Antibody-Drug Conjugates for Solid Tumors: Progress, Possibilities, and Implications for Care

  Рет қаралды 1,633

PeerView Oncology

PeerView Oncology

7 ай бұрын

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.
For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CE/CPE/AAPA information, and to apply for credit, please visit us at PeerView.com/BUC865. CME/NCPD/CE/CPE/AAPA credit will be available until December 9, 2024.
Antibody-Drug Conjugates, the Ultimate Weapons Against Solid Tumors: Latest Progress, Future Possibilities, and Implications for Patient Care
In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Support
This activity is supported by independent educational grants from AstraZeneca and Daiichi Sankyo, Inc.
Disclosure Policy
All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
Faculty/Planner Disclosures
Chair/Planner
Beth Sandy, MSN, CRNP, FAPO, has a financial interest/relationship or affiliation in the form of:
Consultant and/or Advisor for AbbVie Inc. and Janssen Pharmaceuticals, Inc.
Speakers Bureau participant with Amgen Inc.; AstraZeneca; Jazz Pharmaceuticals, Inc.; Lilly; Merck & Co., Inc.; and Takeda Pharmaceutical Company Limited.
Faculty/Planner
Jamie Carroll, APRN, CNP, MSN, has a financial interest/relationship or affiliation in the form of:
Consultant and/or Advisor for Lilly; Novartis Pharmaceuticals Corporation; Pfizer; Sermonix Pharmaceuticals; and Talzenna.
Speakers Bureau participant with Horizon CME and OncLive.
Faculty/Planner
Elizabeth Prechtel Dunphy, DNP, RN, ANP-BC, AOCN, has a financial interest/relationship or affiliation in the form of:
Speakers Bureau participant with Incyte.
Planning Committee and Reviewer Disclosures
Planners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

Пікірлер
Antibody Drug Conjugates for Cancer
56:32
Woo University
Рет қаралды 3,8 М.
Mama vs Son vs Daddy 😭🤣
00:13
DADDYSON SHOW
Рет қаралды 29 МЛН
Самый Молодой Актёр Без Оскара 😂
00:13
Глеб Рандалайнен
Рет қаралды 11 МЛН
A teacher captured the cutest moment at the nursery #shorts
00:33
Fabiosa Stories
Рет қаралды 14 МЛН
Antibody Drug Conjugates: The end of chemotherapy | 2023 West Oncology Conference
27:03
Optimal SCLC Care With Established and Innovative Therapies
1:27:09
PeerView Oncology
Рет қаралды 186
Unlocking the Power of Modern Therapeutic Regimens for Prostate Cancer
1:32:31
What your ANA Pattern means
11:32
Connected Rheumatology
Рет қаралды 18 М.
Decoding Biomarker Testing and Targeted Therapy in NSCLC
1:25:15
PeerView Oncology
Рет қаралды 325
Lung Cancer Breakout: Breakthrough treatments for longer life
31:51
Cancer Research Institute
Рет қаралды 19 М.